title: Genetic analysis in the Asthma Clinical Research Network.
abstract: Because there is reason to believe that genetic variants could account for different treatment responses in subjects with asthma, it is important to collect blood for genetic-analysis purposes when conducting clinical trials in asthma. This article describes issues related to maintaining subject confidentiality, tracking and shipping blood samples, quality control procedures at the laboratory performing the genotyping, and necessary data verification checks when implementing the genetic-analysis database for the Asthma Clinical Research Network.
authors.affiliation: Department of Health Evaluation Sciences, College of Medicine, Pennsylvania State University, Hershey, PA, USA.
authors.forename: P E
authors.initials: PE
authors.lastname: Forand
authors.forename: S J
authors.initials: SJ
authors.lastname: Kunselman
authors.forename: J M
authors.initials: JM
authors.lastname: Drazen
authors.forename: E
authors.initials: E
authors.lastname: Israel
authors.forename: A
authors.initials: A
authors.lastname: Pillari
authors.forename: T J
authors.initials: TJ
authors.lastname: Armstrong
authors.forename: T B
authors.initials: TB
authors.lastname: Britton
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000235:genetics*; D002986:Clinical Trials as Topic / Q000379:methods*; D003219:Confidentiality; D028744:Ethics Committees, Research; D005838:Genotype; D006801:Humans; D011786:Quality Control; D000068299:Salmeterol Xinafoate
chemical_list: D000318:Adrenergic beta-Agonists; D000068299:Salmeterol Xinafoate; D000420:Albuterol